title: Moderate weight loss improves heart rate variability in overweight and obese adults with type 2 diabetes.
abstract: The objective of this study was to determine the effects of weight loss on heart rate variability (HRV) and its association with traditional cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes. Forty five patients [body mass index (BMI) 35.4 ± 0.7 kg/m²; age 56.5 ± 1.1 yr] with type 2 diabetes followed an energy-restricted diet (6-7 MJ/day) for 16 wk. Body weight, blood pressure, glucose, insulin, insulin resistance [homeostasis model assessment index 2 (HOMA2)], glycosylated hemoglobin (HbA1c), total cholesterol, low-density lipoproteins (LDL), high-density lipoproteins (HDL), triglycerides, resting HR, and HRV were measured before and after the intervention period. Mean reduction in body weight was 11.1 ± 1.0 kg (10%), with significant reductions in blood pressure (-10%), total cholesterol (-15.9%), LDL (-17.7%), HDL (-7.5%), triglycerides (-21.2%), glucose (-23.4%), insulin (-37.6%), HOMA2 (-40.1%), and HbA1c (-14.5%) (P ≤ 0.05 for all variables). There were increases in several HRV components, including total power (1,370 ± 280 to 2,045 ± 280 ms²), low-frequency power (345 ± 70 to 600 ± 108 ms²), SD of normal to normal intervals (SDNN; 35.0 ± 2.5 to 43.0 ± 2.7 s), and square root of the mean squared differences of successive normal to normal intervals (RMSSD; 23.0 ± 3.5 to 32.0 ± 3.1 s), and a decrease in HR (69.0 ± 1.3 to 60.0 ± 1.2 beats/min) (P ≤ 0.03 for all variables). Changes in HR, SDNN, total power, and low-frequency power correlated with change in BMI (P < 0.05). In addition to improvements in traditional cardiovascular and metabolic risk factors, weight loss improves HRV in overweight and obese patients with type 2 diabetes.
authors.affiliation: Discipline of Physiology, School of Medical Sciences, University of Adelaide, South Australia.
authors.forename: Nicholas
authors.initials: N
authors.lastname: Sjoberg
authors.forename: Grant D
authors.initials: GD
authors.lastname: Brinkworth
authors.forename: Thomas P
authors.initials: TP
authors.lastname: Wycherley
authors.forename: Manny
authors.initials: M
authors.lastname: Noakes
authors.forename: David A
authors.initials: DA
authors.lastname: Saint
mesh_terms: D001341:Autonomic Nervous System / Q000503:physiopathology*; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight; D002097:C-Reactive Protein / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000178:diet therapy / Q000503:physiopathology*; D004038:Diet, Reducing; D005260:Female; D006339:Heart Rate / Q000502:physiology*; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000097:blood / Q000178:diet therapy / Q000503:physiopathology; D050177:Overweight / Q000097:blood / Q000178:diet therapy / Q000503:physiopathology*; D015431:Weight Loss
chemical_list: D001786:Blood Glucose; D008055:Lipids; D002097:C-Reactive Protein